New pancreatic cancer drug wins FDA approval but access remains limited
2 sourcesUpdated Sep 9, 2026
How it spread
What each side asserts, disputes — or leaves out entirely.
Whose framing of this story rings truest to you?
Left· 1 source
“A breakthrough pancreatic cancer drug won approval. They still struggle to access it”Right· 0 sources
No right coverage yet — a bubble gap.
Free account · your comment posts right after signup
